The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
Open accessAbstract
The current emergency due to the worldwide spread of the COVID-19 caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a great concern for global public health. Already in the past, the outbreak of severe acute respiratory syndrome (SARS) in 2003 and Middle Eastern respiratory syndrome (MERS) in 2012 demonstrates the potential of coronaviruses to cross-species borders and further underlines the importance of identifying new-targeted drugs. An ideal antiviral agent should target essential proteins involved in the lifecycle of SARS-CoV. Currently, some HIV protease inhibitors (i.e., Lopinavir) are proposed for the treatment of COVID-19, although their effectiveness has not yet been assessed. The main protease (Mpro) provides a highly validated pharmacological target for the discovery and design of inhibitors. We identified potent Mpro inhibitors employing computational techniques that entail the screening of a Marine Natural Product (MNP) library. MNP library was screened by a hyphenated pharmacophore model, and molecular docking approaches. Molecular dynamics and re-docking further confirmed the results obtained by structure-based techniques and allowed this study to highlight some crucial aspects. Seventeen potential SARS-CoV-2 Mpro inhibitors have been identified among the natural substances of marine origin. As these compounds were extensively validated by a consensus approach and by molecular dynamics, the likelihood that at least one of these compounds could be bioactive is excellent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A smooth particle mesh Ewald method
Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470117 · Cited by 22,514
Development and testing of a general amber force field
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A., & Case, D. A. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20035 · Cited by 19,506
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00255 · Cited by 10,830
Comparison of multiple Amber force fields and development of improved protein backbone parameters
Hornak, V., Abel, R., Okur, A., Strockbine, B., Roitberg, A., & Simmerling, C. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.21123 · Cited by 6,914
Duan, Y., Wu, C., Chowdhury, S., Lee, M. C., Xiong, G., Zhang, W., Yang, R., Cieplak, P., Luo, R., Lee, T., et al. (2003) · Journal of Computational Chemistry · doi:10.1002/jcc.10349 · Cited by 4,441
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
Jakalian, A., Jack, D. B., & Bayly, C. I. (2002) · Journal of Computational Chemistry · doi:10.1002/jcc.10128 · Cited by 3,426
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Chen, Y., Liu, Q., & Guo, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25681 · Cited by 3,062
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
YASARA View—molecular graphics for all devices—from smartphones to workstations
Krieger, E., & Vriend, G. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu426 · Cited by 1,568
Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field
Krieger, E., Koraimann, G., & Vriend, G. (2002) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10104 · Cited by 1,514
A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment
Munster, V. J., Koopmans, M., van Doremalen, N., van Riel, D., & de Wit, E. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2000929 · Cited by 1,415
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,265
New ways to boost molecular dynamics simulations
Krieger, E., & Vriend, G. (2015) · Journal of Computational Chemistry · doi:10.1002/jcc.23899 · Cited by 1,067
Pharmacophore modeling and applications in drug discovery: challenges and recent advances
Yang, S.-Y. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.013 · Cited by 901
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 775
Fast empirical pKa prediction by Ewald summation
Krieger, E., Nielsen, J. E., Spronk, C. A. E. M., & Vriend, G. (2006) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2006.02.009 · Cited by 473
Pharmit: interactive exploration of chemical space
Sunseri, J., & Koes, D. R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw287 · Cited by 420
Liu, L., Heinrich, M., Myers, S., & Dworjanyn, S. A. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.05.046 · Cited by 398
Heo, S.-J., Ko, S.-C., Cha, S.-H., Kang, D.-H., Park, H.-S., Choi, Y.-U., Kim, D., Jung, W.-K., & Jeon, Y.-J. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.05.013 · Cited by 320
Stewart, J. J. P. (2004) · Journal of Molecular Modeling · doi:10.1007/s00894-004-0183-z · Cited by 302
Xu, Z., Shi, D., Han, J.-B., Ling, Y., Jiang, X., Lu, X., Li, C., Gong, L., Ge, G., Zhang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01429-0 · Cited by 301
Krieger, E., Dunbrack, R. L., Hooft, R. W. W., & Krieger, B. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-465-0_25 · Cited by 286
Li, Y., Fu, X., Duan, D., Liu, X., Xu, J., & Gao, X. (2017) · Marine Drugs · doi:10.3390/md15020049 · Cited by 272
Mayer, A. M. S., Rodríguez, A. D., Berlinck, R. G. S., & Fusetani, N. (2011) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2010.08.008 · Cited by 270
Chen, L., Li, J., Luo, C., Liu, H., Xu, W., Chen, G., Liew, O. W., Zhu, W., Puah, C. M., Shen, X., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.014 · Cited by 265
Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava
Artan, M., Li, Y., Karadeniz, F., Lee, S.-H., Kim, M.-M., & Kim, S.-K. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.078 · Cited by 235
Kong, C.-S., Kim, J.-A., Yoon, N.-Y., & Kim, S.-K. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.04.013 · Cited by 233
Identification of Novel Inhibitors of the SARS Coronavirus Main Protease 3CLpro
Bacha, U., Barrila, J., Velazquez-Campoy, A., Leavitt, S. A., & Freire, E. (2004) · Biochemistry · doi:10.1021/bi0361766 · Cited by 218
Yoon, N. Y., Eom, T.-K., Kim, M.-M., & Kim, S.-K. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900006f · Cited by 188
Dieckol, a SARS-CoV 3CLpro inhibitor, isolated from the edible brown algae Ecklonia cava
Park, J.-Y., Kim, J. H., Kwon, J. M., Kwon, H.-J., Jeong, H. J., Kim, Y. M., Kim, D., Lee, W. S., & Ryu, Y. B. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.026 · Cited by 186
Bzówka, M., Mitusińska, K., Raczyńska, A., Samol, A., Tuszyński, J. A., & Góra, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093099 · Cited by 171
Ghosh, A. K., Xi, K., Ratia, K. M., Santarsiero, B. D., Fu, W., Harcourt, B. H., Rota, P. A., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050548m · Cited by 142
Li, Y., Lee, S., Le, Q.-T., Kim, M., & Kim, S. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf802732n · Cited by 135
Shie, J., Fang, J., Kuo, T., Kuo, C., Liang, P., Huang, H., Wu, Y.-T., Jan, J., Cheng, Y. E., & Wong, C. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.065 · Cited by 111
Myung, C., Shin, H., Bao, H. Y., Yeo, S. J., Lee, B. H., & Kang, J. S. (2005) · Archives of Pharmacal Research · doi:10.1007/bf02969360 · Cited by 110
Barf, T. A., Lehmann, F., Hammer, K., Haile, S., Axén, E., Medina, C., Uppenberg, J., Svensson, S., Rondahl, L., & Lundbäck, T. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.084 · Cited by 109
Ghosh, A. K., Xi, K., Grum-Tokars, V. L., Xu, X., Ratia, K. M., Fu, W., Houser, K. V., Baker, S. C., Johnson, M. E., & Mesecar, A. D. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.08.031 · Cited by 102
Apigenin inhibits renal cell carcinoma cell proliferation
Meng, S., Zhu, Y., Li, J., Wang, X., Liang, Z. C., Li, S., Xu, X., Chen, H., Liu, B., Zheng, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15771 · Cited by 90
Zhang, R., Kang, K. A., Piao, M. J., Ko, D. O., Wang, Z. H., Lee, I. K., Kim, B., Jeong, I. Y., Shin, T., Park, J. W., et al. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.086 · Cited by 61
Pseudotheonamides, Serine Protease Inhibitors from the Marine Sponge Theonella swinhoei1
Nakao, Y., Masuda, A., Matsunaga, S., & Fusetani, N. (1999) · Journal of the American Chemical Society · doi:10.1021/ja9831195 · Cited by 47
Samet, I., Villareal, M. O., Motojima, H., Han, J., Sayadi, S., & Isoda, H. (2015) · Differentiation · doi:10.1016/j.diff.2015.07.001 · Cited by 38
Floresta, G., Amata, E., Barbaraci, C., Gentile, D., Turnaturi, R., Marrazzo, A., & Rescifina, A. (2018) · Marine Drugs · doi:10.3390/md16100384 · Cited by 33
Self-citationQiao, F., Luo, L., Peng, H., Luo, S., Huang, W., Cui, J., Li, X., Kong, L., Jiāng, D., Chitwood, D. J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160003 · Cited by 30
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach
Floresta, G., Gentile, D., Perrini, G., Patamia, V., & Rescifina, A. (2019) · Marine Drugs · doi:10.3390/md17110624 · Cited by 26
Self-citationDib, R. E. M. E., Moharram, F. A.-E., Marzouk, M., El-Shenawy, S. M. A., & Ibrahim, H. A. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_344_16 · Cited by 15
Cited by
COCONUT online: Collection of Open Natural Products database
Sorokina, M., Merseburger, P., Rajan, K., Yirik, M. A., & Steinbeck, C. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-020-00478-9 · Cited by 665
Seaweed Phenolics: From Extraction to Applications
Cotas, J., Leandro, A., Monteiro, P., Pacheco, D., Figueirinha, A., Gonçalves, A. M. M., da Silva, G. J., & Pereira, L. (2020) · Marine Drugs · doi:10.3390/md18080384 · Cited by 525
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Structural Basis of Potential Inhibitors Targeting SARS-CoV-2 Main Protease
Mengist, H. M., Dilnessa, T., & Jin, T. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.622898 · Cited by 302
da Silva, J. K. R., Figueiredo, P. L. B., Byler, K. G., & Setzer, W. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103426 · Cited by 284
Metadata
- Authors
- Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2020-04-23
- Volume
- 18
- Issue
- 4
- Pages
- 225
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W3013223828
- Cited by
- 319
- References
- 49
- FWCI
- 33.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.